Repurposing FDA-approved drugs may help combat COVID-19
The Pharma Data
FEBRUARY 25, 2022
Several FDA-approved drugs – including for type 2 diabetes, hepatitis C and HIV – significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. 25) in the journal Communications Biology.
Let's personalize your content